HopeStage
Back to all studies
RecruitingNCT05834478

Active or sham noninvasive vagus nerve stimulation and opioid withdrawal responses

About this titleRead the official source — NCT05834478
Medication studyAges 18–75United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 75 years.

Listed locations
Atlanta and 5 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 20, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
103
Sponsor
Emory University
Sponsor type
University
Study type
Drug
Intervention type
Device, Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT05834478
Official title
Show the full official title

Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3

Recruitment & locations

Currently recruiting

Atlanta

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Emory University, a university.

Does this study involve medication?

Yes. The study involves medication, including [F-18]Fallypride.

Who can participate?

Listed age limits: 18 years to 75 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies